+1 #(S1 (S (NP (NN _PROT1_)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ C-terminal) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))))) (CC and) (VP (VBZ inhibits) (NP (PRP$ its) (JJ enzymatic) (NN activity))))))
+1 #(S1 (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT the) (JJ stable) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT2_)))) (PP (IN in) (NP (NP (DT a) (JJ clathrin-coated) (NN vesicle) (NN complex)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (CONJP (RB not) (RB only)) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ carboxyl-terminal) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT_)))))) (, ,) (CONJP (CC but) (RB also)) (VP (VBZ inhibits) (NP (PRP$ its) (JJ enzymatic) (NN activity)) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT the) (JJ stable) (NN association)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT_)))) (PP (IN in) (NP (NP (DT a) (JJ clathrin-coated) (NN vesicle) (NN complex)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (CONJP (RB not) (RB only)) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ carboxyl-terminal) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT2_)))))) (, ,) (CONJP (CC but) (RB also)) (VP (VBZ inhibits) (NP (PRP$ its) (JJ enzymatic) (NN activity)) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))))))))))))
+1 #(S1 (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT the) (JJ stable) (NN association)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT1_)))) (PP (IN in) (NP (NP (DT a) (JJ clathrin-coated) (NN vesicle) (NN complex)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (CONJP (RB not) (RB only)) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ carboxyl-terminal) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT2_)))))) (, ,) (CONJP (CC but) (RB also)) (VP (VBZ inhibits) (NP (PRP$ its) (JJ enzymatic) (NN activity)) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))))))))))))
+1 #(S1 (S (NP (NP (DT The) (NN protein) (NN _PROT1_) (NNS functions)) (PP (IN in) (NP (DT a) (JJ multi-subunit) (NN E3) (NN ubiquitin) (NN ligase))) (SBAR (WHNP (WDT that)) (S (VP (VBZ targets) (NP (NP (DT the) (JJ hypoxia-inducible) (NN transcription) (NN factor)) (NP (NN _PROT2_) (NN _PROT2_))) (PP (IN for) (NP (JJ proteasomal) (NN degradation))) (PP (IN during) (NP (NN normoxia)))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP establish) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ binds) (PP (TO to) (NP (NP (NP (JJ _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (NP (DT the) (NN 19S) (JJ regulatory) (NN complex)) (PP (IN of) (NP (DT the) (NN proteasome))))))))))))))
+1 #(S1 (S (NP (PRP We)) (VP (VBP establish) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ binds) (PP (TO to) (NP (NP (NP (JJ _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (NP (DT the) (NN 19S) (JJ regulatory) (NN complex)) (PP (IN of) (NP (DT the) (NN proteasome))))))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBP establish) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (NP (NP (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (NP (DT the) (NN 19S) (JJ regulatory) (NN complex)) (PP (IN of) (NP (DT the) (NN proteasome))))))))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT2_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_) (NN _PROT_))))))) (ADVP (FW in) (FW vivo)))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_) (NN _PROT_))))))) (ADVP (FW in) (FW vivo)))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))))))) (ADVP (FW in) (FW vivo)))))
-1 #(S1 (S (NP (NN _PROT_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_) (NN _PROT_))))))) (ADVP (FW in) (FW vivo)))))
-1 #(S1 (S (NP (NN _PROT_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))))))) (ADVP (FW in) (FW vivo)))))
-1 #(S1 (S (NP (NN _PROT_)) (VP (VBZ associates) (PP (IN with) (NP (NP (NP (DT the) (NN beta-domain)) (PP (IN of) (NP (NN _PROT_)))) (CC and) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))))))) (ADVP (FW in) (FW vivo)))))
+1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ promotes) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))) (PP (IN in) (NP (NP (DT a) (JJ pVHL-dependent) (NN manner)) (SBAR (WHNP (WDT that)) (S (VP (VBZ requires) (NP (NP (DT the) (NN ATPase) (NN domain)) (PP (IN of) (NP (NN _PROT_))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ promotes) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT_) (NN _PROT_)))) (PP (IN in) (NP (NP (DT a) (JJ pVHL-dependent) (NN manner)) (SBAR (WHNP (WDT that)) (S (VP (VBZ requires) (NP (NP (DT the) (NN ATPase) (NN domain)) (PP (IN of) (NP (NN _PROT2_))))))))))))
+1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ promotes) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT1_) (NN _PROT1_)))) (PP (IN in) (NP (NP (DT a) (JJ pVHL-dependent) (NN manner)) (SBAR (WHNP (WDT that)) (S (VP (VBZ requires) (NP (NP (DT the) (NN ATPase) (NN domain)) (PP (IN of) (NP (NN _PROT2_))))))))))))
+1 #(S1 (S (NP (NP (NN Blockade)) (PP (IN of) (NP (NN _PROT1_) (NN expression))) (PP (IN by) (NP (NP (JJ small) (VBG interfering) (NN RNA)) (PRN (-LRB- -LRB-) (NP (NN siRNA)) (-RRB- -RRB-))))) (VP (VBZ causes) (NP (NP (JJ prolonged) (NN degradation) (NN kinetics)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))))))
-1 #(S1 (S (NP (NP (JJ Several) (JJ distinct) (NNS mutations)) (PP (IN in) (NP (NP (NN exon) (CD 2)) (PP (IN of) (NP (NNS _PROT1_)))))) (VP (VBP disrupt) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT2_))) (PP (TO to) (NP (NN _PROT_)))))))
+1 #(S1 (S (NP (NP (JJ Several) (JJ distinct) (NNS mutations)) (PP (IN in) (NP (NP (NN exon) (CD 2)) (PP (IN of) (NP (NNS _PROT1_)))))) (VP (VBP disrupt) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT_))) (PP (TO to) (NP (NN _PROT2_)))))))
+1 #(S1 (S (NP (NP (JJ Several) (JJ distinct) (NNS mutations)) (PP (IN in) (NP (NP (NN exon) (CD 2)) (PP (IN of) (NP (NNS _PROT_)))))) (VP (VBP disrupt) (NP (NP (NN binding)) (PP (IN of) (NP (NN _PROT1_))) (PP (TO to) (NP (NN _PROT2_)))))))
+1 #(S1 (S (NP (NP (DT A) (JJ _PROT1_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT_) (NN _PROT_)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ _PROT1_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT_) (NN _PROT_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT2_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT_) (NN _PROT_)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ _PROT1_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT_) (NN _PROT_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ _PROT_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT1_) (NN _PROT1_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT2_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT_) (NN _PROT_)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ _PROT_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT1_) (NN _PROT1_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))))))))
-1 #(S1 (S (NP (NP (DT A) (JJ _PROT_) (NN mutant)) (VP (VBG containing) (NP (DT a) (NN P154L) (NN substitution)))) (VP (VP (VBZ coimmunoprecipitates) (PP (IN with) (NP (NP (NN _PROT_) (NN _PROT_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT1_)) (, ,)))) (CC and) (VP (VBZ does) (RB not) (VP (VB promote) (NP (NP (NN degradation)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_)))))))))
+1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT1_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT2_) (NN _PROT2_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
+1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT1_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT2_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT1_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT1_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT2_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT1_) (NN _PROT1_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT2_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT1_) (NN _PROT1_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT1_) (NN _PROT1_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT2_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT1_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT_) (NNS tumors))))))))))
-1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT1_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT_) (NN _PROT_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT2_) (NNS tumors))))))))))
+1 #(S1 (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN _PROT_))) (S (VP (TO to) (VP (VB degrade) (NP (NN _PROT_) (NN _PROT_)))))) (VP (VP (VBZ depends) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN _PROT_)))))) (CC and) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (NN mechanism)) (PP (IN for) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN stabilization)) (PP (IN in) (NP (DT some) (JJ _PROT2_) (NNS tumors))))))))))
+1 #(S1 (S (NP (NP (NN Cross-linking)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NN mAb) (NN MEM-53)))) (CC and) (NP (DT a) (JJ polyclonal) (NN sheep) (JJ anti-mouse) (NN Ig))))) (VP (VP (VBD promoted) (NP (NP (NN activation)) (PP (IN of) (NP (VBG resting) (NN B) (NNS cells))) (PP (IN into) (NP (NP (DT the) (NN G1) (NN phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle)))))) (SBAR (IN as) (S (VP (VBN judged) (PP (IN by) (NP (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (DT the) (JJ early) (NN activation) (NN Ag) (NN _PROT2_)))) (, ,) (NP (NP (NNS increases)) (PP (IN in) (NP (JJ cellular) (NN volume)))) (, ,) (NP (NN RNA) (NN synthesis)) (, ,) (CC and) (NP (NN _PROT_) (NN protein) (NNS levels)))))))) (, ,) (CC and) (VP (VBD enhanced) (NP (NP (NN binding)) (PP (IN of) (NP (NN 7-aminoactinomycin) (NN D))))))))
+1 #(S1 (S (NP (NP (NN Cross-linking)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NN mAb) (NN MEM-53)))) (CC and) (NP (DT a) (JJ polyclonal) (NN sheep) (JJ anti-mouse) (NN Ig))))) (VP (VP (VBD promoted) (NP (NP (NN activation)) (PP (IN of) (NP (VBG resting) (NN B) (NNS cells))) (PP (IN into) (NP (NP (DT the) (NN G1) (NN phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle)))))) (SBAR (IN as) (S (VP (VBN judged) (PP (IN by) (NP (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (DT the) (JJ early) (NN activation) (NN Ag) (NN _PROT_)))) (, ,) (NP (NP (NNS increases)) (PP (IN in) (NP (JJ cellular) (NN volume)))) (, ,) (NP (NN RNA) (NN synthesis)) (, ,) (CC and) (NP (NN _PROT2_) (NN protein) (NNS levels)))))))) (, ,) (CC and) (VP (VBD enhanced) (NP (NP (NN binding)) (PP (IN of) (NP (NN 7-aminoactinomycin) (NN D))))))))
-1 #(S1 (S (NP (NP (NN Cross-linking)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NN mAb) (NN MEM-53)))) (CC and) (NP (DT a) (JJ polyclonal) (NN sheep) (JJ anti-mouse) (NN Ig))))) (VP (VP (VBD promoted) (NP (NP (NN activation)) (PP (IN of) (NP (VBG resting) (NN B) (NNS cells))) (PP (IN into) (NP (NP (DT the) (NN G1) (NN phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle)))))) (SBAR (IN as) (S (VP (VBN judged) (PP (IN by) (NP (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (DT the) (JJ early) (NN activation) (NN Ag) (NN _PROT1_)))) (, ,) (NP (NP (NNS increases)) (PP (IN in) (NP (JJ cellular) (NN volume)))) (, ,) (NP (NN RNA) (NN synthesis)) (, ,) (CC and) (NP (NN _PROT2_) (NN protein) (NNS levels)))))))) (, ,) (CC and) (VP (VBD enhanced) (NP (NP (NN binding)) (PP (IN of) (NP (NN 7-aminoactinomycin) (NN D))))))))
-1 #(S1 (S (ADVP (RB However)) (, ,) (NP (NNS cytokines)) (, ,) (PP (IN in) (NP (JJ particular) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))) (, ,) (VP (VBD potentiated) (NP (NP (DT the) (NN DNA) (NN synthesis)) (VP (VBN induced) (PP (IN by) (NP (NP (NN cross-linking)) (PP (IN of) (NP (NN _PROT_))))))))))
+1 #(S1 (S (ADVP (RB However)) (, ,) (NP (NNS cytokines)) (, ,) (PP (IN in) (NP (JJ particular) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (, ,) (VP (VBD potentiated) (NP (NP (DT the) (NN DNA) (NN synthesis)) (VP (VBN induced) (PP (IN by) (NP (NP (NN cross-linking)) (PP (IN of) (NP (NN _PROT2_))))))))))
+1 #(S1 (S (ADVP (RB However)) (, ,) (NP (NNS cytokines)) (, ,) (PP (IN in) (NP (JJ particular) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (, ,) (VP (VBD potentiated) (NP (NP (DT the) (NN DNA) (NN synthesis)) (VP (VBN induced) (PP (IN by) (NP (NP (NN cross-linking)) (PP (IN of) (NP (NN _PROT2_))))))))))
-1 #(S1 (S (NP (DT The) (NP (JJ human) (NN _PROT1_) (NN mRNA) (NN editing)) (NN protein)) (VP (VBZ is) (NP (NP (DT a) (NN _PROT2_) (NN _PROT2_)) (VP (VBG showing) (NP (JJ structural) (NN homology)) (PP (TO to) (NP (DT some) (JJ known) (UCP (ADJP (JJ mammalian)) (CC and) (NP (NN bacteriophage))) (NN deoxycytidylate) (NNS deaminases))))))))
-1 #(S1 (S (NP (DT The) (NN fact) (SBAR (IN that) (S (NP (DT the) (NP (NN _PROT1_) (NN mRNA) (NN editing)) (NN protein)) (ADVP (RB also)) (VP (VBZ exists) (PP (IN as) (NP (DT a) (NN _PROT2_))))))) (VP (VBZ has) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN _PROT_) (NN mRNA) (NN editing))) (PP (IN in) (NP (NNS humans)))))))))
-1 #(S1 (S (NP (DT The) (NN fact) (SBAR (IN that) (S (NP (DT the) (NP (NN _PROT1_) (NN mRNA) (NN editing)) (NN protein)) (ADVP (RB also)) (VP (VBZ exists) (PP (IN as) (NP (DT a) (NN _PROT_))))))) (VP (VBZ has) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN _PROT2_) (NN mRNA) (NN editing))) (PP (IN in) (NP (NNS humans)))))))))
-1 #(S1 (S (NP (DT The) (NN fact) (SBAR (IN that) (S (NP (DT the) (NP (NN _PROT_) (NN mRNA) (NN editing)) (NN protein)) (ADVP (RB also)) (VP (VBZ exists) (PP (IN as) (NP (DT a) (NN _PROT1_))))))) (VP (VBZ has) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN _PROT2_) (NN mRNA) (NN editing))) (PP (IN in) (NP (NNS humans)))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT_) (-LRB- _PROT_) (CD _PROT_) (-RRB- _PROT_) (CD _PROT_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT_)))))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT1_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT2_) (-LRB- _PROT2_) (CD _PROT2_) (-RRB- _PROT2_) (CD _PROT2_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT_)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT_) (-LRB- _PROT_) (CD _PROT_) (-RRB- _PROT_) (CD _PROT_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT2_)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT2_) (-LRB- _PROT2_) (CD _PROT2_) (-RRB- _PROT2_) (CD _PROT2_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT_)))))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT_) (-LRB- _PROT_) (CD _PROT_) (-RRB- _PROT_) (CD _PROT_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT2_)))))))))))))))
+1 #(S1 (S (NP (NP (NN _PROT_) (NNS dimers)) (VP (VP (VBN formed) (PP (IN through) (NP (NP (NN self-association)) (PP (IN of) (NP (DT the) (JJ TATA-binding) (NN polypeptide) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (NN subunit)))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN _PROT1_) (-LRB- _PROT1_) (CD _PROT1_) (-RRB- _PROT1_) (CD _PROT1_)) (, ,) (NP (NP (DT the) (NN core) (NN subunit)) (PP (IN of) (NP (NN _PROT2_)))))))))))))))
